With gains of 7.21%, Exact Sciences was one of the winners on Wall Street today. Its shares are now trading at $67.47 and have logged a 1.5% daily outperformance of the S&P 500. Don't join the feeding frenzy before checking some basic facts about this stock:
-
Exact Sciences has moved -11.7% over the last year, and the S&P 500 logged a change of -8.02%
-
EXAS has an average analyst rating of buy and is -6.37% away from its mean target price of $72.06 per share
-
Its trailing earnings per share (EPS) is $-3.67
-
Exact Sciences has a trailing 12 month Price to Earnings (P/E) ratio of -18.38 while the S&P 500 average is 15.97
-
Its forward earnings per share (EPS) is $-1.85 and its forward P/E ratio is -36.47
-
The company has a Price to Book (P/B) ratio of 2.603 in contrast to the S&P 500's average ratio of 2.95
-
Exact Sciences is part of the Consumer Cyclical sector, which has an average P/E ratio of 22.33 and an average P/B of 3.12
-
Exact Sciences Corporation offers cancer screening and diagnostic test products in the United States and internationally. The company is headquartered in Madison, Wisconsin.